🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a phase 2, multicenter, single-arm study with a safety lead-in to i...
Status
Active Not Recruiting
Location
Beijing Cancer Hospital
Start Date
2022-06-02
Trial ID
NCT05195632
Treatments Being Tested
This study is looking at outcomes in people with advanced cancers who have ...
Status
Terminated
Location
Peter MacCallum Cancer Centre
Start Date
2021-09-23
Trial ID
NCT04801966
This phase II trial studies how well encorafenib and binimetinib given with...
Status
Active Not Recruiting
Location
Providence Portland Medical Center
Start Date
2020-10-30
Trial ID
NCT04061980
Treatments Being Tested
This clinical trial is to clarify whether treatment with a checkpoint inhib...
Status
Recruiting
Location
Herlev Universityhospital
Start Date
2018-06-06
Trial ID
NCT03563729
The purpose of the Columbus-AD study is to evaluate the efficacy and safety...
Status
Active Not Recruiting
Location
Centro Oncologico Korben
Start Date
2022-05-02
Trial ID
NCT05270044
Treatments Being Tested
This multicenter, retrospective observational study aims to identify clinic...
Status
Completed
Location
Ankara Etlik City Hospital
Start Date
2022-11-15
Trial ID
NCT07256184
Treatments Being Tested
This phase II trial studies the effects of binimetinib and encorafenib in t...
Status
Recruiting
Location
M D Anderson Cancer Center
Start Date
2021-12-27
Trial ID
NCT05026983
Treatments Being Tested
This phase II trial studies the side effects and how well the combination o...
Status
Terminated
Location
Mayo Clinic in Arizona
Start Date
2020-11-16
Trial ID
NCT04390243
Treatments Being Tested
The purpose of this study is to learn about the effects of three study medi...
Status
Active Not Recruiting
Location
Adventist Health System/Sunbelt, Inc.
Start Date
2021-01-15
Trial ID
NCT04657991
Treatments Being Tested
This is a multicenter Phase 1b, open-label study to evaluate the pharmacoki...
Status
Terminated
Location
Fondazione IRCCS Istituto Nazionale Dei Tumori
Start Date
2020-08-03
Trial ID
NCT03878719
Treatments Being Tested